Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New issues in infectious diarrhea.

Nancy F Crum1, Mark R Wallace, Edward C Oldfield

  • 1Infectious Diseases Division, Naval Medical Center San Diego, San Diego, California, USA.

Reviews in Gastroenterological Disorders
|August 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary Intake of Micro- and Nanoplastics: Potential Adverse GI Effects on Microbiome, Inflammation, and Neoplasia.

Microorganisms·2026
Same author

A Comprehensive Narrative Review of Potential Gastrointestinal Adverse Effects From Micro(nano) Plastic Exposure.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Plastics: Here, There, and Everywhere: Implications for Gastrointestinal Health and Disease.

The American journal of gastroenterology·2025
Same author

Prescribing Colonoscopy Bowel Preparations: Tips for Maximizing Outcomes.

The American journal of gastroenterology·2022
Same author

Immunity against measles in people with HIV: the need for more research and surveillance.

AIDS (London, England)·2022
Same author

Coccidioidomycosis: A Contemporary Review.

Infectious diseases and therapy·2022

Infectious diarrhea is a major global health issue. New antibiotics like Rifaximin show promise for treatment and prevention, while vaccine development faces challenges due to diverse pathogens.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Infectious diarrhea causes significant global mortality and morbidity.
  • Emerging pathogens and changing trends of known pathogens like Clostridium difficile present ongoing challenges.
  • Rising antimicrobial resistance necessitates the study of novel therapeutic agents.

Purpose of the Study:

  • To review the current landscape of infectious diarrhea, including novel pathogens and evolving trends.
  • To highlight the potential of Rifaximin, a nonabsorbable antibiotic, in treating and preventing infectious diarrhea.
  • To discuss the challenges and importance of developing vaccines against diarrheagenic organisms.

Main Methods:

  • Literature review of recent findings on infectious diarrhea pathogens and epidemiology.

Related Experiment Videos

  • Analysis of clinical data and research on the efficacy of Rifaximin.
  • Discussion of vaccine development strategies and obstacles.

    • Main Results:

    • Novel organisms are increasingly identified as causes of diarrhea.
    • A new epidemic strain of Clostridium difficile is associated with severe cases and antibiotic resistance.
    • Rifaximin is approved for travelers' diarrhea and shows potential for other gastrointestinal disorders.

    Conclusions:

    • Infectious diarrhea remains a critical global health concern requiring novel therapeutic approaches.
    • Rifaximin represents a promising option for managing certain types of infectious diarrhea.
    • Vaccine development for diarrheagenic organisms is crucial but complex due to pathogen diversity.